Nuclear medicine treatments use very small, carefully controlled amounts of radioactive material that decay to nontoxic levels within minutes to days, making them far less taxing on the body than standard chemotherapy. Cathy Cutler, PhD, FSNMMI, of Brookhaven National Laboratory joins Dr. Mitchell to address the fear many patients feel at the word "nuclear," explaining how these treatments target cancer cells directly while leaving healthy tissue largely untouched. She discusses new alpha-emitting isotopes now helping patients who have run out of other options, the workforce and supply challenges facing the field, and why patients on these therapies often report a far better quality of life than those on traditional chemotherapy.
Connect with Cathy Cutler:Social Media:LinkedInWebsites:isotopes.govResources/Publications:Radiopharmaceutical Therapy: Rapid Growth, Rising Challenges, and the Critical Need for Expertise — J Nucl MedPET Drugs — 2023 Workshop Proceedings — J Nucl MedContact Dr. Mitchell:Email: care@mitchellmedicalgroup.com
WebsiteInstagramYouTubeFacebookLinkedInBook:
Conquering CandidaImmunoLytics - code SmartestDoc, 5% off
Apollo Neuro - code SMARTMD
